Trials / Completed
CompletedNCT00688402
Study to Compare Different Formulations of AZD3355
A Double-blind, Randomized, Cross-over Design, Phase 1 Pharmacodynamic Study to Investigate the Effect of Different Formulations of AZD3355 for the Development of Paresthesiae After Dosing in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to compare different formulations of AZD3355 in regard to possible adverse events such as sensations of numbness, tinglings and heat in the skin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD3355 | Single dose |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-06-03
- Last updated
- 2010-12-03
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00688402. Inclusion in this directory is not an endorsement.